Current Studies
We are looking for subjects to test the safety and efficacy of an injection in potentially treating osteoarthritis (OA) of the knee. This study will look at how well an investigational study therapy works at addressing some of the symptoms of osteoarthritis (OA) of the knee.
We are enrolling patients in a new clinical study for moderate to severe knee pain to evaluate a very unique investigational injection treatment. A tiny amount of your own stem cells from abdominal adipose tissues is placed in the joints of your knee, which may help improve your symptoms and delay the progression of knee osteoarthritis by restoring damaged cartilage.
This study is currently at capacity.
An estimated 6.7 million Americans age 65 and older will be living with Alzheimer's in 2023. We are looking for patients between the ages of 50 to 80 years-old to join this research study in an effort to slow the progression of Alzheimer’s Disease.
Neurovations is currently enrolling in a new study for chronic lower back pain for patients 18 years and older. This study includes a single investigational intradiscal injection that could provide up to 6 months of clinically meaningful symptomatic relief.
We are looking for men and women ages 18 years or older with knee pain from osteoarthritis. This is a clinic-based study that involves one injection to the painful knee.
We are enrolling patients in a new clinical study for moderate to severe knee pain to evaluate a very unique investigational injection treatment. A tiny amount of your own stem cells from abdominal adipose tissues is placed in the joints of your knee, which may help improve your symptoms and delay the progression of knee osteoarthritis by restoring damaged cartilage.
This study is currently at capacity.
We are looking for subjects to test the safety and efficacy of an injection in potentially treating osteoarthritis (OA) of the knee. This study will look at how well an investigational study therapy works at addressing some of the symptoms of osteoarthritis (OA) of the knee.
We are looking for men and women ages 18 years or older with knee pain from osteoarthritis. This is a clinic-based study that involves one injection to the painful knee.
Neurovations is currently enrolling in a new study for chronic lower back pain for patients 18 years and older. This study includes a single investigational intradiscal injection that could provide up to 6 months of clinically meaningful symptomatic relief.
An estimated 6.7 million Americans age 65 and older will be living with Alzheimer's in 2023. We are looking for patients between the ages of 50 to 80 years-old to join this research study in an effort to slow the progression of Alzheimer’s Disease.
Neurovations
Neurovations, a patient care and innovation company, was founded in 1992 by CEO Dr. Eric Grigsby. Today, Neurovations is a national leader in medical device and pharmaceutical innovation, clinical research, and a world-class education program focusing in pain and neuroscience. Dr. Grigsby is deeply connected to the healthcare community through our non-profit HealthRoots Foundation and to the Napa community through Rocca Family Vineyards, a producer of award-winning wines.
Our unwavering mission is to inspire hope and to contribute to the health and well-being of our patients and communities through integrated clinical practice, research, and education.